Datasets (28,470)

Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.

Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma

Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia

Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq)

RNA-seq of human normal lung and lung cancer tissue

Transcriptome studies of marine natural products 4a and 4d on non-small cell lung cancer A549 cells

High-throughput sequence analysis of peripheral T-cell lymphomas indicates subtype specific viral gene expression patterns and immune cell microenvironments

Disparate anticancer activity of structurally similar multi-kinase inhibitors through cumulative differential effects on individual targets

Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq)

Genome-wide expression analysis of EPCAM+ epithelial cells from 3-dimensional lung organoids harboring Hermansky-Pudlak Syndrome-associated mutations

Antibody crossreactivity with mRNA cap accounts for widespread appearance of m1A throughout the transcriptome

Convergence of BMI1 and CHD7 on ERK signalling in medulloblastoma

Transcriptomic analysis of 5637 bladder cancer cell line transfected with MAT1A plamid, 48 hours post transfection

LIX1L stabilization of CCL20 promotes fibrosis

RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown